BIEI - Premier Biomedical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0850
-0.0100 (-10.53%)
At close: 3:48PM EST
Stock chart is not supported by your current browser
Previous Close0.0950
Open0.0670
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.0525 - 0.0850
52 Week Range0.0014 - 0.5600
Volume80,000
Avg. Volume64,452
Market Cap409,075
Beta (3Y Monthly)1.93
PE Ratio (TTM)N/A
EPS (TTM)-0.287
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE8 days ago

    Premier Biomedical Signs Agreement With CBD HEMP Distributing Company to Distribute Premier’s Topical Pain Relief Products In Four Northeastern States

    JACKSON CENTER, PA / ACCESSWIRE / December 6, 2018 / Premier Biomedical, Inc (OTC: BIEI) a research based publicly traded biomedical company has signed a sales and distribution agreement with CBD Hemp Distributing Company, a newly formed company part of a conglomerate.The company, whose members have an extensive network of sales contacts in the retail pharmaceutical and pain management medical industry, will have exclusive distribution rights to Premier Biomedical's topical pain relief products in four Northeastern States of the U.S.This move augments the growing number of regional sales representatives and local distributors Premier Biomedical has scattered throughout the country. Ralph Blundo and Ron Patrick, principals in CBD HEMP DISTRIBUTING COMPANY are excited about the opportunity to distribute the high quality CBD products designed by Premier Biomedical.

  • ACCESSWIRElast month

    Premier Biomedical, Inc. CEO Letter - October, 2018

    An anticipated boost to CBD topical products is expected upon passage of the pending Senate Bill #S-2667, which clarifies hemp derived CBD as federally legal and acceptable for use in certain medical applications.

  • GlobeNewswire2 months ago

    Premier Biomedical, Inc.’s CEO Discusses a Bright Future for His Company and All-Natural Solutions with Uptick Newswire’s Stock Day Podcast

    Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases. CEO and President, William A. Hartman, was welcomed back to Stock Day by Everett Jolly. Hartman started off by telling Jolly he had a lot to cover in this interview and got right to it.

  • ACCESSWIRE2 months ago

    MoneyTV with Donald Baillargeon, 10/26

    LOS ANGELES, CA / ACCESSWIRE / October 26, 2018 / Crowdfunding, cannabis payments, disruptive water company, CBD pain relief, protecting consumers, new civil war; this week on MoneyTV with Donald Baillargeon. ...

  • OTC Markets Group Announces Quarterly Index Performance and Rebalancing
    PR Newswire2 months ago

    OTC Markets Group Announces Quarterly Index Performance and Rebalancing

    NEW YORK , Oct. 17, 2018 /PRNewswire/ --   OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the third quarter 2018 performance ...

  • GlobeNewswire2 months ago

    Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast

    Premier Biomedical, Inc. (OTCQB:BIEI) (“Premier Biomedical, Inc.” or the “company”) is looking for new strategies and joint ventures to sell CBD. Mr. Jolly asked Mr. Hartman where Premier Biomedical, Inc. stands on a recent joint venture.

  • ACCESSWIRE4 months ago

    ICYMI - Premier Biomedical CEO Interviewed on Money TV

    In Case You Missed It - Mr. Hartman Discusses Recent Accomplishments and New Opportunities JACKSON CENTER, PA / ACCESSWIRE / August 28, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI ) President and CEO, ...

  • ACCESSWIRE4 months ago

    Premier Biomedical, Inc. President and CEO, William Hartman Discusses Company Updates Since July 2018 and Their 250:1-Split with Everett Jolly on Uptick Newswire's ''Stock Day'' Podcast

    JACKSON CENTER, PA / ACCESSWIRE / August 27, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI) (the "Company") announced President and CEO, William A. Hartman's interview on Uptick Newswire's "Stock Day" Podcast. Everett Jolly began the interview by welcoming back Premier Biomedical, Inc. President and CEO, William A. Hartman for a Company update since July 2018. Jolly stated that he still thinks this Company is undervalued even after their 250:1-split.

  • ACCESSWIRE4 months ago

    MoneyTV with Donald Baillargeon, 8/24

    LOS ANGELES, CA / ACCESSWIRE / August 24, 2018 / Logistics, self-driving cars, water conference, CBD, cannabis, Unhappy Meals; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...

  • ACCESSWIRE4 months ago

    Premier Biomedical, Inc. Creates Four Centers of Technological Expertise

    JACKSON CENTER, PA / ACCESSWIRE / August 21, 2018 / Premier Biomedical, Inc. (OTCQB: " BIEI "), a research based publicly traded biomedical company, announced that it has created four interrelated ...

  • ACCESSWIRE4 months ago

    PainReliefMeds.com Resumes Credit Card Processing

    Issues Related to the Suspension of Credit Card Processing Have Been Resolved JACKSON CENTER, PA / ACCESSWIRE / August 15, 2018 / PainReliefMeds.com , the website which sells the topical pain relief treatments ...

  • ACCESSWIRE4 months ago

    Premier Biomedical Signs Agreement With Sales Group to Represent Premier's Topical Pain Relief Products to the Military

    JACKSON CENTER, PA / ACCESSWIRE / August 7, 2018 / Premier Biomedical, Inc (OTCQB: BIEI) a research based publicly traded biomedical company has signed a sales representative agreement with 4 Your Pain, LLC, a newly formed company whose members have extensive experience in selling medical products to the U.S. Department of Defense and other governmental agencies. The group also has experience and connections in selling to long term care facilities, which Premier Biomedical has targeted for its topical pain relief products. 4 Your Pain's executive team released a statement saying that, "We are excited to partner with Premier Biomedical in getting their pain relief products out to the individuals in need of relief from pain they have to deal with on a daily basis.

  • ACCESSWIRE5 months ago

    Premier Biomedical, Inc. Uplifted to OTCQB

    BIEI Trading on OTCQB Effective July 27, 2018 JACKSON CENTER, PA / ACCESSWIRE / July 30, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI ) a research based publicly traded biomedical company announced that ...

  • ACCESSWIRE5 months ago

    Premier Biomedical, Inc. Ceo Letter - July, 2018

    As we moved further into our new role, we realized that we would be a far stronger company if we were to represent our multi-faceted technologies as potentially independent business units. While we are continuing to develop a revenue-producing hemp oil CBD business, we are continuing to develop intellectual property based on our core extracorporeal patented technology.

  • ACCESSWIRE6 months ago

    Premier Biomedical, Inc. Effects Reverse Split

    FINRA Approves BIEI 250:1 Reverse Stock Split Effective June 27, 2018 JACKSON CENTER, PA / ACCESSWIRE / June 27, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI ) a research-based publicly traded biomedical ...

  • ACCESSWIRE6 months ago

    MoneyTV with Donald Baillargeon, 6/8

    LOS ANGELES, CA / ACCESSWIRE / June 8, 2018 / CBD-based pain relief, bitcoin trading academy, 3D medical imaging, electronic payments, the power of THEY; this week on MoneyTV with Donald Baillargeon. MoneyTV ...

  • ACCESSWIRE6 months ago

    Premier Biomedical's CEO, William A. Hartman, Visits Uptick Newswire's "Stock Day" with Marcus Heatherly

    JACKSON CENTER, PA / ACCESSWIRE / June 4, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI) President & CEO, William A. Hartman was recently interviewed by Marcus Heatherly on Uptick Newswire's "Stock Day" podcast. Premier Biomedical, Inc. has evolved since its inception in 2010. The company first went public in 2012, and in 2013 the leadership team signed a Cooperative Research And Development Agreement with the Department of Defense to develop a treatment for PTSD together with the University of Texas at El Paso.

  • ACCESSWIRE7 months ago

    MoneyTV with Donald Baillargeon, 5/25

    LOS ANGELES, CA / ACCESSWIRE / May 25, 2018 / Spirits industry, CBD, cryptocurrrency, cannabis, Swamp-Gate; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television ...

  • ACCESSWIRE7 months ago

    MoneyTV with Donald Baillargeon, 5/18

    LOS ANGELES, CA / ACCESSWIRE / May 18, 2018 / Legal sports betting, pain relief, cryptocurrency, blockchain, CBD; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated ...

  • ACCESSWIRE8 months ago

    Premier Biomedical, Inc. CEO Letter - April 2018

    It has been a very busy and eventful quarter for Premier Biomedical. The problem for the company's position was the issued and outstanding shares (those in circulation) represented approximately 70% of the authorized shares level. In order to ensure a beneficial split for our shareholders and the company, we instituted actions to elevate the resultant stock price to a level in the range of $0.50 - $1.00, significantly reducing our outstanding shares to approximately 3 million shares while maintaining the authorized number of shares at 1 billion shares.

  • ACCESSWIRE8 months ago

    MoneyTV with Donald Baillargeon, 4/13

    LOS ANGELES, CA / ACCESSWIRE / April 13, 2018 / Pain relief, cancer treatment, blockchain and cryptocurrency, water cleanup, cannabis business, organic teas, US/China trade war; this week on MoneyTV with ...